ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,193Medicare Part D Prescriptions Filled, Including Refills

Rank: 422 out of 1456

$692K Total Retail Price of All Prescriptions

Rank: 274 out of 1456

171 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 171 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 171 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 5,431 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

54 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
QUETIAPINE FUMARATE 396 173 1 78
LISINOPRIL 330 185 2 3
RISPERIDONE 302 136 3 72
FUROSEMIDE 302 233 3 7
SIMVASTATIN 241 156 5 2
OMEPRAZOLE 241 137 5 5
SERTRALINE HCL 214 103 7 25
AMLODIPINE BESYLATE 212 105 8 1
LEVETIRACETAM 192 62 9 97
BENZTROPINE MESYLATE 187 95 R 10 222
METFORMIN HCL 187 65 10 8
FAMOTIDINE 175 116 12 45
KLOR-CON M20 168 112 13 51
LANTUS 160 72 14 50
LEVOTHYROXINE SODIUM 157 90 15 4
SEROQUEL 136 63 16 154
WARFARIN SODIUM 134 117 17 21
METOPROLOL TARTRATE 128 74 18 12
HALOPERIDOL 124 14 19 254
HYDROCODONE-ACETAMINOPHEN 104 74 S3 20 6
DONEPEZIL HCL 104 92 20 29
GLIPIZIDE ER 102 56 22 86
GABAPENTIN 99 44 23 13
CLONIDINE HCL 98 70 24 39
TAMSULOSIN HCL 98 80 24 34
OXYBUTYNIN CHLORIDE ER 95 60 26 167
KLOR-CON M10 94 75 27 140
MIRTAZAPINE 93 57 28 65
DIVALPROEX SODIUM ER 91 0 29 227
ATENOLOL 90 49 30 18
HALOPERIDOL DECANOATE 89 15 31 435
CARVEDILOL 87 70 32 20
NAMENDA 86 77 33 38
HYDROCHLOROTHIAZIDE 80 42 34 10
TRAZODONE HCL 70 21 35 47
CLOPIDOGREL 63 41 36 32
POLYETHYLENE GLYCOL 3350 62 60 37 85
RISPERDAL CONSTA 61 18 38 406
DIVALPROEX SODIUM 59 15 39 108
NOVOLIN R 58 27 40 133
OLANZAPINE 56 0 41 183
PREDNISONE 54 43 42 42
POTASSIUM CHLORIDE 53 49 43 15
COLCRYS 52 43 44 122
PLAVIX 52 38 44 46
ATORVASTATIN CALCIUM 51 30 46 11
CHLORPROMAZINE HCL 51 13 46 495
PRAVASTATIN SODIUM 50 25 48 9
SPIRONOLACTONE 50 50 48 73
FLUTICASONE PROPIONATE 50 37 48 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.